◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

RECURSION PHARMACEUTICALS, INC.

CIK: 1601830 SIC: 2836
$74.68M
Revenue
$-644.76M
Net Income
4.99%
Gross Margin
-867.87%
Op. Margin
$-725.42M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 5 annual reports available (2021 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
+ Total Revenue $74.68M $74.68M $58.84M $44.58M $39.84M $10.18M
Revenue Growth % 0.0% 26.9% 32.0% 11.9% 291.5% nan%
Cost of Revenue $70.95M $70.95M $45.24M $42.59M $48.27M -
+ Gross Profit $3.73M $3.73M $13.60M $1.99M $-8.43M $10.18M
Gross Margin % 5.0% 5.0% 23.1% 4.5% -21.2% 100.0%
Operating Expenses $722.81M $722.81M $537.84M $394.63M $285.57M $192.95M
Research & Development $475.27M $475.27M $314.42M $241.23M $155.70M $135.27M
+ Operating Income $-648.13M $-648.13M $-479.00M $-350.06M $-245.73M $-182.78M
Operating Margin % -867.9% -867.9% -814.1% -785.3% -616.7% -1795.8%
Interest Expense - $1.81M $1.57M $96.00K $55.00K $680.00K
Other Income/Expense $3.24M $3.24M $14.22M $17.93M $6.25M $-3.70M
Income Before Tax $-644.89M $-644.89M $-464.79M $-332.13M $-239.48M $-186.48M
Income Tax Expense $-135.00K $-136.00K $-1.13M $-4.06M - -
+ Net Income $-644.76M $-644.76M $-463.66M $-328.07M $-239.48M $-186.48M
Net Margin % -863.4% -863.4% -788.0% -736.0% -601.0% -1832.2%
Basic EPS -1.44 -1.44 -1.69 -1.58 -1.36 -1.49
Diluted EPS -1.44 -1.44 -1.69 -1.58 -1.36 -1.49
Basic Shares Outstanding - 447.4M 274.2M 207.9M 175.5M 125.3M
Diluted Shares Outstanding - 447.4M 274.2M 207.9M 175.5M 125.3M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Cash & Cash Equivalents $743.29M $594.35M $391.56M $549.91M $285.12M
Short-term Investments - - - - $231.45M
Accounts Receivable - - - - $34.00K
Other Current Assets $28.57M $67.71M $40.25M $15.87M $7.51M
Total Current Assets $812.85M $714.27M $438.14M $569.81M $534.72M
Property Plant & Equipment $103.93M $141.06M $86.51M $88.19M $64.72M
Goodwill $162.16M $148.87M $52.06M $801.00K $801.00K
Intangible Assets $309.90M $335.86M $36.44M $1.31M $1.39M
Other Non-current Assets $12.75M $8.82M $261.00K - $35.00K
Total Assets $1.47B $1.45B $653.70M $701.29M $610.35M
Accounts Payable $18.12M $21.61M $3.95M $4.59M $2.82M
Accrued Liabilities $70.23M $81.87M $46.63M $32.90M $32.33M
Deferred Revenue $37.60M $61.77M $36.43M $56.73M $10.00M
Total Current Liabilities $147.71M $187.47M $93.17M $100.27M $46.66M
Long-term Debt $9.56M $19.02M $1.10M - -
Deferred Tax Liabilities $23.25M $16.57M $1.34M - -
Other Non-current Liabilities $2.08M $4.73M - - -
Total Liabilities $343.26M $413.82M $190.26M $215.48M $67.41M
Common Stock $5.00K $4.00K $2.00K $2.00K $2.00K
Retained Earnings $-2.08B $-1.43B $-967.62M $-639.56M $-400.08M
Total Stockholders Equity $1.13B $1.03B $463.44M $485.81M $542.94M
Total Liabilities & Equity $1.47B $1.45B $653.70M $701.29M $610.35M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Net Income $-847.25M $-644.76M $-463.66M $-328.07M $-239.48M $-186.48M
Depreciation & Amortization $146.21M $83.70M $36.49M $24.40M $11.76M $8.40M
Stock-based Compensation $209.50M $111.22M $81.69M $53.50M $27.91M $14.84M
Deferred Income Tax - $-368.00K $-1.63M $-4.06M - -
Change in Receivables - - - - - $-114.00K
Change in Payables $-69.00K $-2.62M $6.43M $-987.00K $1.77M $1.75M
Operating Cash Flow $-712.14M $-371.81M $-359.17M $-287.78M $-83.52M $-158.61M
Capital Expenditure $13.28M $6.47M $13.70M $11.96M $37.06M $39.80M
Acquisitions - - $-277.10M $-1.84M - -
Purchases of Investments $6.31M $3.81M - - - -
Investing Cash Flow $-37.22M $-16.87M $260.06M $-10.23M $193.25M $-271.74M
Debt Repayment - - - $766.00K $90.00K $12.80M
Stock Issued $710.91M $528.86M $300.42M $128.09M $143.71M -
Financing Cash Flow $700.25M $521.53M $304.12M $140.13M $154.34M $458.54M
Net Change in Cash $-12.15M $150.90M $201.60M $-157.69M $263.76M $28.18M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $5.17M $26.08M $39.14M $54.29M
Cost of Revenue $14.69M $12.08M $56.68M $32.44M
Operating Expenses $177.38M $124.44M $578.94M $349.53M
Research & Development $121.06M $74.60M $379.33M $216.09M
Operating Income $-172.20M $-98.35M $-539.80M $-295.24M
Other Income/Expense $9.95M $2.68M $3.00M $9.35M
Income Before Tax $-162.25M $-95.67M $-536.79M $-285.89M
Income Tax Expense $3.00K $167.00K $-156.00K $-1.13M
Net Income $-162.25M $-95.84M $-536.64M $-284.75M
Basic EPS -0.36 -0.34 -1.27 -1.12
Diluted EPS -0.36 -0.34 -1.27 -1.12
Basic Shares Outstanding $446.99M $282.58M $422.64M $253.45M
Diluted Shares Outstanding $446.99M $282.58M $422.64M $253.45M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $659.84M $594.35M
Other Current Assets $29.22M $38.11M
Total Current Assets $714.11M $714.27M
Property Plant & Equipment $111.71M $141.06M
Goodwill $162.04M $148.87M
Intangible Assets $322.34M $335.86M
Other Non-current Assets $14.66M $8.82M
Total Assets $1.40B $1.45B
Accounts Payable $13.94M $21.61M
Accrued Liabilities $53.10M $81.87M
Deferred Revenue $47.36M $61.77M
Total Current Liabilities $155.10M $187.47M
Long-term Debt $11.90M $19.02M
Deferred Tax Liabilities $23.31M $16.57M
Other Non-current Liabilities $1.03M $4.73M
Total Liabilities $352.58M $413.82M
Common Stock $5.00K $4.00K
Retained Earnings $-1.97B $-1.43B
Total Stockholders Equity $1.05B $1.03B
Total Liabilities & Equity $1.40B $1.45B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-162.25M $-95.84M $-536.64M $-284.75M
Depreciation & Amortization - - $64.22M $23.54M
Stock-based Compensation - - $87.46M $50.90M
Change in Payables - - $-7.04M $-1.69M
Operating Cash Flow - - $-325.74M $-243.74M
Capital Expenditure - - $5.22M $12.40M
Purchases of Investments - - $3.81M -
Investing Cash Flow - - $-15.63M $-15.40M
Stock Issued - - $395.48M $289.39M
Financing Cash Flow - - $389.53M $293.48M
Net Change in Cash - - $64.12M $34.41M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading news...
TRENDING
Loading...